News

25.06.2018
New Canadian study to improve eradication of inhibitors in Hemophilia A patients

Toronto, Canada, June 25, 2018: – Octapharma announced today the launch of the Canadian PREVAIL (Imm...

18.06.2018
Octapharma announces approval of new Nuwiq® product strengths in Europe, increasing dosing flexibility for patients with haemophilia A

Lachen, Switzerland 18 June 2018: Octapharma announced today that the European Medicines Agency...

Since its establishment over 30 years ago, Octapharma has grown into a truly global company providing life enhancing therapies to patients in over 100 countries. To find your local Octapharma office, access our global locations map

“As a world-wide provider of human proteins as treatments in immunotherapy, haematology, and intensive care and emergency medicine, Octapharma is constantly investing in the renovation and modernisation of our plants.„

Wolfgang Marguerre
Chairman of the Board